Topical α-gal nanoparticles accelerate diabetic wound healing
- PMID: 32027409
- DOI: 10.1111/exd.14084
Topical α-gal nanoparticles accelerate diabetic wound healing
Abstract
An inadequate response from macrophages, key orchestrators of the wound healing process, has been implicated in the pathophysiology of impaired healing in diabetes. This study explored the utility of nanoparticles presenting the α-gal (Galα1-3Galβ1-4GlcNAc-R) epitope to induce anti-Gal antibody-mediated local transient recruitment of macrophages to accelerate wound closure and healing in a diabetic murine model. α1,3galactosyltrasferase knockout mice were stimulated to produce anti-Gal antibodies and subsequently diabetes was induced by streptozotocin-induced β-cell destruction. Six mm full-thickness skin wounds were made and α-gal nanoparticles (AGN) were topically applied on postwounding days 0 and 1. Wounds were analysed histologically for macrophage invasion and markers of wound healing, including epithelialization, vascularization and granulation tissue deposition through postoperative day 12. We found that application of AGN transiently but significantly increased macrophage recruitment into the wounds of diabetic mice. Treated wounds demonstrated more rapid closure and enhanced wound healing as demonstrated by significantly accelerated rates of epithelialization, vascularization and granulation tissue deposition. Thus, topical treatment of full-thickness wounds in diabetic mice with α-gal nanoparticles induced a transient but significant increase in macrophage recruitment resulting in an accelerated rate of wound healing. Using α-gal nanoparticles as a topical wound healing adjunct is a simple, safe and effective means of augmenting dysregulated macrophage recruitment present in the diabetic state.
Keywords: animal model; epidermis; keratinocytes; macrophages; wound healing.
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Similar articles
-
Antigen-Mediated, Macrophage-Stimulated, Accelerated Wound Healing Using α-Gal Nanoparticles.Ann Plast Surg. 2018 Apr;80(4 Suppl 4):S196-S203. doi: 10.1097/SAP.0000000000001360. Ann Plast Surg. 2018. PMID: 29481481
-
Acceleration of wound healing by α-gal nanoparticles interacting with the natural anti-Gal antibody.J Immunol Res. 2015;2015:589648. doi: 10.1155/2015/589648. Epub 2015 Apr 1. J Immunol Res. 2015. PMID: 25922849 Free PMC article. Review.
-
Rapid recruitment and activation of macrophages by anti-Gal/α-Gal liposome interaction accelerates wound healing.J Immunol. 2011 Apr 1;186(7):4422-32. doi: 10.4049/jimmunol.1002324. Epub 2011 Feb 25. J Immunol. 2011. PMID: 21357545 Free PMC article.
-
Topical α-Gal Nanoparticles Enhance Wound Healing in Radiated Skin.Skin Pharmacol Physiol. 2022;35(1):31-40. doi: 10.1159/000518015. Epub 2021 Jun 24. Skin Pharmacol Physiol. 2022. PMID: 34348342 Free PMC article.
-
α-Gal Nanoparticles in Wound and Burn Healing Acceleration.Adv Wound Care (New Rochelle). 2017 Mar 1;6(3):81-92. doi: 10.1089/wound.2016.0703. Adv Wound Care (New Rochelle). 2017. PMID: 28289553 Free PMC article. Review.
Cited by
-
Fostering a healthy culture: Biological relevance of in vitro and ex vivo skin models.Exp Dermatol. 2021 Mar;30(3):298-303. doi: 10.1111/exd.14296. Epub 2021 Feb 10. Exp Dermatol. 2021. PMID: 33565670 Free PMC article. No abstract available.
-
Advances and perspective on animal models and hydrogel biomaterials for diabetic wound healing.Biomater Transl. 2022 Sep 28;3(3):188-200. doi: 10.12336/biomatertransl.2022.03.003. eCollection 2022. Biomater Transl. 2022. PMID: 36654776 Free PMC article. Review.
-
Immunomodulation in age-related disorders and nanotechnology interventions.Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023 Jan;15(1):e1840. doi: 10.1002/wnan.1840. Epub 2022 Aug 10. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023. PMID: 35950266 Free PMC article. Review.
-
Chiral Supramolecular Hydrogel Loaded with Dimethyloxalyglycine to Accelerate Chronic Diabetic Wound Healing by Promoting Cell Proliferation and Angiogenesis.Gels. 2022 Jul 13;8(7):437. doi: 10.3390/gels8070437. Gels. 2022. PMID: 35877522 Free PMC article.
-
Antibody production and tolerance to the α-gal epitope as models for understanding and preventing the immune response to incompatible ABO carbohydrate antigens and for α-gal therapies.Front Mol Biosci. 2023 Jun 28;10:1209974. doi: 10.3389/fmolb.2023.1209974. eCollection 2023. Front Mol Biosci. 2023. PMID: 37449060 Free PMC article. Review.
References
REFERENCES
-
- W. R. Rowley, C. Bezold, Y. Arikan, E. Byrne, S. Krohe, Popul. Health Manag. 2017, 20, 6.
-
- L. A. Lavery, D. G. Armstrong, R. P. Wunderlich, J. Tredwell, A. J. Boulton, Diabetes Care 2003, 26, 1435.
-
- K. Stockl, A. Vanderplas, E. Tafesse, E. Chang, Diabetes Care 2004, 27, 2129.
-
- R. J. Snyder, J. R. Hanft, Ostomy/Wound Manage. 2009, 55, 28.
-
- L. A. Lavery, D. G. Armstrong, R. P. Wunderlich, M. J. Mohler, C. S. Wendel, B. A. Lipsky, Diabetes Care, 2006, 29, 1288.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical